note highlight event catalyst space anticip june well
highlight week
expect june
parent project muscular dystrophi annual confer june scottsdal az
gather intellig gene therapi program dmd particular broadli
compil event come
soon space follow
highlight week
dmd pipelin program
week recap
kiniksa mo pt risk-adjust dcf-deriv initi coverag establish
price target see report
clinic stage compani focu develop therapi autoimmun inflammatori
disord near-term catalyst multipl front
lead asset rilonacept interim data on-going phase trial recurr pericard
expect
initi phase studi recurr pericard expect year follow phase regulatori
convers fda
track initi proof-of-concept phase trial mavrilimumab giant cell arter gca
expect phase data atop dermat expans prurigo
sarepta mo pt ur risk-adjust dcf-deriv except gene therapi data
day see note
micro-dystrophin gene therapi data srpt day tuesday blew away expect
express level extraordinari drop ck biomark muscl damag
sarepta current think re-dos strategi includ use plasmapheresi prior dose
clear neutral antibodi could expand initi potenti popul well
step dose three patient cohort biopsi three month data later
year parallel sarepta start double-blind placebo-control cohort patient expect
serv registr studi endpoint inform observ cohort
heron mo pt risk-adjust dcf-deriv posit phase data pain program
two addit indic see note
breakthrough statu award think speak data desir fda opioid-
report read conjunct import disclosur inform includ attest regul analyst certif
strong data two pain new studi add program includ seven differ
surgic subtyp support broad label potenti opioid-spar includ
label view win differenti competit
phase studi total knee arthroplasti tka breast augment
demonstr signific pain reduct reduct opioid usag compar placebo
increas risk-adjust dcf deriv price target
previous acceler launch trajectori reach peak penetr
vs previou peak penetr
jmp-host life scienc confer wrap note day day
jmp annual life scienc confer highlight panel discuss compani
key opinion leader area focus gene therapi food allergi emerg nash
landscap along firesid chat present compani coverag univers
figur select upcom event coverag univers
yearexpect opinion mepsevii data jakafi acut macrilen diagnos adult growth hormon defici sonic data recorlev third cohort phase achiev studi inarigivir file decis phase hefh data european societi cardiolog orakmbi children age year advisori committe date kalydeco children age month data ali treat refractori ntm caus achndata second group first studi trial palisad complet data phaseout dmd studi data recorlev cush data rtrxstart clinic test sparsentan iga studi add-on therapi three-month data pnh patient receiv open-label phase long-term golodirsen anim tox necessari roll ali nda data phase tripl combo phase movement disord data approv decis teza/iva rams data interim data cohort interim data cohort snda jakafi acut data phase mg inarigivir co-administ trial children age bla viaskin peanut phase lca data data phase trial data studi ole cohort mg phase achiev trial end golodirsen roll nda end complet re-examin process end bla end enrol phase fort trial end goal start phase nash studi phase myonexu regulatori applic ali japan
research analyst prepar report does/do herebi certifi view present report accord my/our
person view secur issuer discuss report mandat sec regul ac part my/our compens
directli indirectli relat specif view recommend express herein certif made
oblig set forth sec regul ac person entiti may use purpos certif made
base my/our analysi date report public i/w assum oblig updat certif reflect fact
circumst event may subsequ come my/our attent sign liisa bayko jonathan wolleben
jmp secur current make market secur arbutu biopharma corp achillion pharmaceut inc aimmun
inc strongbridg biopharma plc spring bank pharmaceut inc summit therapeut plc sarepta therapeut inc vertex
jmp secur receiv compens bank servic render madrig pharmaceut inc spring bank
pharmaceut inc past month
jmp secur manag co-manag public offer secur inc ltd
inc summit therapeut plc smmt
past month receiv compens
jmp secur and/or affili obtain posit least equiti secur
ordinari cours its/their business/invest
jmp secur expect receiv intend seek compens invest bank servic arbutu biopharma corp achillion
pharmaceut inc inc spring bank pharmaceut inc summit therapeut plc sarepta
therapeut inc next month
issuer number underwrit includ jmp secur among other defend class action lawsuit issuer
indemnifi underwrit connect therewith pursuant term applic underwrit agreement
market outperform mo jmp secur expect stock price outperform relev market indic next month
market perform mp jmp secur expect stock price perform line relev market indic next month
market under-perform mu jmp secur expect stock price under-perform relev market indic next month
jmp secur research rate invest bank servic june
servic
co
stock price chart rate price chang
note first annot denot initi coverag year whichev shorter target price list target price n/a
accord finra rule chart reflect price rang chang rate price target end
recent calendar quarter action reflect note annot stock price chart jmp secur
order obtain stock price chart addit applic disclosur inform concern jmp recommend
